The Binding Energetics of First- and Second-Generation HIV-1 Protease Inhibitors: Implications for Drug Design
- 15 June 2001
- journal article
- Published by Elsevier BV in Archives of Biochemistry and Biophysics
- Vol. 390 (2), 169-175
- https://doi.org/10.1006/abbi.2001.2333
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Thermodynamic Basis of Resistance to HIV-1 Protease Inhibition: Calorimetric Analysis of the V82F/I84V Active Site Resistant MutantBiochemistry, 2000
- Sequence Note: Analysis of HIV Type 1 Protease and Reverse Transcriptase in Antiretroviral Drug-Naive Ugandan AdultsAIDS Research and Human Retroviruses, 2000
- HIV-1 Protease Inhibitors: Enthalpic versus Entropic Optimization of the Binding AffinityBiochemistry, 2000
- JE-2147: A dipeptide protease inhibitor (PI) that potently inhibits multi-PI-resistant HIV-1Proceedings of the National Academy of Sciences of the United States of America, 1999
- Structure−Activity Relationship of Small-Sized HIV Protease Inhibitors Containing AllophenylnorstatineJournal of Medicinal Chemistry, 1999
- Counteracting HIV-1 Protease Drug Resistance: Structural Analysis of Mutant Proteases Complexed with XV638 and SD146, Cyclic Urea Amides with Broad SpecificitiesBiochemistry, 1998
- Resistance to HIV Protease Inhibitors: A Comparison of Enzyme Inhibition and Antiviral PotencyBiochemistry, 1998
- Structural Mechanisms of HIV Drug ResistanceAnnual Review of Pharmacology and Toxicology, 1996
- Crystal Structures of Complexes of a Peptidic Inhibitor with Wild-Type and Two Mutant HIV-1 Proteases,Biochemistry, 1996
- Effect of Point Mutations on the Kinetics and the Inhibition of Human Immunodeficiency Virus Type 1 Protease: Relationship to Drug ResistanceBiochemistry, 1995